Comparison  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
tumefactive  ||| S:14 E:26 ||| JJ
demyelinating  ||| S:26 E:40 ||| JJ
lesions  ||| S:40 E:48 ||| NNS
and  ||| S:48 E:52 ||| CC
glioma  ||| S:52 E:59 ||| NN
by  ||| S:59 E:62 ||| IN
clinical  ||| S:62 E:71 ||| JJ
presentations  ||| S:71 E:85 ||| NNS
and  ||| S:85 E:89 ||| CC
neuroimaging  ||| S:89 E:102 ||| JJ
studies  ||| S:102 E:110 ||| NNS
To  ||| S:110 E:113 ||| TO
explore  ||| S:113 E:121 ||| VB
the  ||| S:121 E:125 ||| DT
clinical  ||| S:125 E:134 ||| JJ
and  ||| S:134 E:138 ||| CC
imaging  ||| S:138 E:146 ||| JJ
features  ||| S:146 E:155 ||| NNS
of  ||| S:155 E:158 ||| IN
tumefactive  ||| S:158 E:170 ||| FW
demyelinating  ||| S:170 E:184 ||| FW
lesions  ||| S:184 E:192 ||| FW
( ||| S:192 E:193 ||| -LRB-
TDL ||| S:193 E:196 ||| NNP
)  ||| S:196 E:198 ||| -RRB-
and  ||| S:198 E:202 ||| CC
glioma ||| S:202 E:208 ||| NN
.  ||| S:208 E:210 ||| .
The  ||| S:210 E:214 ||| DT
brain  ||| S:214 E:220 ||| NN
computed  ||| S:220 E:229 ||| NN
tomography  ||| S:229 E:240 ||| NNS
( ||| S:240 E:241 ||| -LRB-
CT ||| S:241 E:243 ||| NNP
) ||| S:243 E:244 ||| -RRB-
,  ||| S:244 E:246 ||| ,
magnetic  ||| S:246 E:255 ||| JJ
resonance  ||| S:255 E:265 ||| NN
imaging  ||| S:265 E:273 ||| NN
( ||| S:273 E:274 ||| -LRB-
MRI ||| S:274 E:277 ||| NNP
)  ||| S:277 E:279 ||| -RRB-
and  ||| S:279 E:283 ||| CC
proton  ||| S:283 E:290 ||| JJ
magnetic  ||| S:290 E:299 ||| JJ
resonance  ||| S:299 E:309 ||| NN
spectroscopy  ||| S:309 E:322 ||| NNS
( ||| S:322 E:323 ||| -LRB-
( ||| S:323 E:324 ||| -LRB-
1 ||| S:324 E:325 ||| LS
) ||| S:325 E:326 ||| -RRB-
H-MRS ||| S:326 E:331 ||| NNP
)  ||| S:331 E:333 ||| -RRB-
features  ||| S:333 E:342 ||| VBZ
of  ||| S:342 E:345 ||| IN
60  ||| S:345 E:348 ||| CD
pathologically  ||| S:348 E:363 ||| NNS
confirmed  ||| S:363 E:373 ||| VBD
TDL  ||| S:373 E:377 ||| NNP
patients  ||| S:377 E:386 ||| NNS
and  ||| S:386 E:390 ||| CC
65  ||| S:390 E:393 ||| CD
glioma  ||| S:393 E:400 ||| CD
ones ||| S:400 E:404 ||| NNS
,  ||| S:404 E:406 ||| ,
hospitalized  ||| S:406 E:419 ||| VBN
at  ||| S:419 E:422 ||| IN
Navy  ||| S:422 E:427 ||| NNP
General  ||| S:427 E:435 ||| NNP
Hospital  ||| S:435 E:444 ||| NNP
from  ||| S:444 E:449 ||| IN
2005  ||| S:449 E:454 ||| CD
to  ||| S:454 E:457 ||| TO
2013 ||| S:457 E:461 ||| CD
,  ||| S:461 E:463 ||| ,
were  ||| S:463 E:468 ||| VBD
reviewed  ||| S:468 E:477 ||| VBN
and  ||| S:477 E:481 ||| CC
analyzed ||| S:481 E:489 ||| VBD
.  ||| S:489 E:491 ||| .
The  ||| S:491 E:495 ||| DT
mean  ||| S:495 E:500 ||| JJ
onset  ||| S:500 E:506 ||| NN
age  ||| S:506 E:510 ||| NN
of  ||| S:510 E:513 ||| IN
glioma  ||| S:513 E:520 ||| NN
was  ||| S:520 E:524 ||| VBD
significantly  ||| S:524 E:538 ||| RB
older  ||| S:538 E:544 ||| JJR
than  ||| S:544 E:549 ||| IN
that  ||| S:549 E:554 ||| DT
of  ||| S:554 E:557 ||| IN
TDL ||| S:557 E:560 ||| NNP
.  ||| S:560 E:562 ||| .
The  ||| S:562 E:566 ||| DT
onset  ||| S:566 E:572 ||| JJ
symptom  ||| S:572 E:580 ||| NN
was  ||| S:580 E:584 ||| VBD
headache  ||| S:584 E:593 ||| VBN
for  ||| S:593 E:597 ||| IN
TDL  ||| S:597 E:601 ||| NNP
and  ||| S:601 E:605 ||| CC
headache  ||| S:605 E:614 ||| NN
and  ||| S:614 E:618 ||| CC
epilepsy  ||| S:618 E:627 ||| NN
for  ||| S:627 E:631 ||| IN
glioma ||| S:631 E:637 ||| NN
.  ||| S:637 E:639 ||| .
The  ||| S:639 E:643 ||| DT
features  ||| S:643 E:652 ||| NNS
of  ||| S:652 E:655 ||| IN
lesions  ||| S:655 E:663 ||| NNS
on  ||| S:663 E:666 ||| IN
brain  ||| S:666 E:672 ||| NN
CT  ||| S:672 E:675 ||| NN
scan ||| S:675 E:679 ||| NNS
:  ||| S:679 E:681 ||| :
no  ||| S:681 E:684 ||| DT
hyperdensity  ||| S:684 E:697 ||| NN
in  ||| S:697 E:700 ||| IN
TDL  ||| S:700 E:704 ||| NNP
group  ||| S:704 E:710 ||| NN
and  ||| S:710 E:714 ||| CC
39  ||| S:714 E:717 ||| CD
with  ||| S:717 E:722 ||| IN
hyperdense  ||| S:722 E:733 ||| JJ
lesions  ||| S:733 E:741 ||| NNS
in  ||| S:741 E:744 ||| IN
glioma  ||| S:744 E:751 ||| JJ
group ||| S:751 E:756 ||| NN
.  ||| S:756 E:758 ||| .
Tissue  ||| S:758 E:765 ||| NN
necrosis  ||| S:765 E:774 ||| NNS
was  ||| S:774 E:778 ||| VBD
more  ||| S:778 E:783 ||| RBR
frequently  ||| S:783 E:794 ||| RB
found  ||| S:794 E:800 ||| VBN
in  ||| S:800 E:803 ||| IN
lesions  ||| S:803 E:811 ||| NNS
of  ||| S:811 E:814 ||| IN
glioma  ||| S:814 E:821 ||| NN
than  ||| S:821 E:826 ||| IN
TDL ||| S:826 E:829 ||| NNP
,  ||| S:829 E:831 ||| ,
especially  ||| S:831 E:842 ||| RB
for  ||| S:842 E:846 ||| IN
higher  ||| S:846 E:853 ||| JJR
grade  ||| S:853 E:859 ||| NN
glioma ||| S:859 E:865 ||| NN
.  ||| S:865 E:867 ||| .
And  ||| S:867 E:871 ||| CC
increased  ||| S:871 E:881 ||| JJ
β  ||| S:881 E:883 ||| NN
and  ||| S:883 E:887 ||| CC
γ-Glx  ||| S:887 E:893 ||| JJ
on  ||| S:893 E:896 ||| IN
( ||| S:896 E:897 ||| -LRB-
1 ||| S:897 E:898 ||| LS
) ||| S:898 E:899 ||| -RRB-
H-MRS  ||| S:899 E:905 ||| NNP
was  ||| S:905 E:909 ||| VBD
most  ||| S:909 E:914 ||| RBS
frequently  ||| S:914 E:925 ||| RB
found  ||| S:925 E:931 ||| VBN
in  ||| S:931 E:934 ||| IN
TDL ||| S:934 E:937 ||| NNP
.  ||| S:937 E:939 ||| .
The  ||| S:939 E:943 ||| DT
onset  ||| S:943 E:949 ||| JJ
age  ||| S:949 E:953 ||| NN
of  ||| S:953 E:956 ||| IN
glioma  ||| S:956 E:963 ||| NN
is  ||| S:963 E:966 ||| VBZ
older  ||| S:966 E:972 ||| JJR
than  ||| S:972 E:977 ||| IN
TDL ||| S:977 E:980 ||| NNP
.  ||| S:980 E:982 ||| .
The  ||| S:982 E:986 ||| DT
headache  ||| S:986 E:995 ||| NN
is  ||| S:995 E:998 ||| VBZ
the  ||| S:998 E:1002 ||| DT
top  ||| S:1002 E:1006 ||| JJ
onset  ||| S:1006 E:1012 ||| NN
symptoms  ||| S:1012 E:1021 ||| NNS
of  ||| S:1021 E:1024 ||| IN
TDL  ||| S:1024 E:1028 ||| NNP
and  ||| S:1028 E:1032 ||| CC
epiplesy  ||| S:1032 E:1041 ||| NN
occurs  ||| S:1041 E:1048 ||| VBZ
frequently  ||| S:1048 E:1059 ||| RB
only  ||| S:1059 E:1064 ||| RB
in  ||| S:1064 E:1067 ||| IN
glioma ||| S:1067 E:1073 ||| NN
.  ||| S:1073 E:1075 ||| .
The  ||| S:1075 E:1079 ||| DT
hyperdense  ||| S:1079 E:1090 ||| JJ
lesions  ||| S:1090 E:1098 ||| NNS
on  ||| S:1098 E:1101 ||| IN
CT  ||| S:1101 E:1104 ||| NNP
scan  ||| S:1104 E:1109 ||| JJ
support  ||| S:1109 E:1117 ||| NN
more  ||| S:1117 E:1122 ||| RBR
the  ||| S:1122 E:1126 ||| DT
diagnosis  ||| S:1126 E:1136 ||| NN
of  ||| S:1136 E:1139 ||| IN
glioma ||| S:1139 E:1145 ||| NN
.  ||| S:1145 E:1147 ||| .
The  ||| S:1147 E:1151 ||| DT
lesions  ||| S:1151 E:1159 ||| NN
with  ||| S:1159 E:1164 ||| IN
tissue  ||| S:1164 E:1171 ||| NN
necrosis  ||| S:1171 E:1180 ||| NNS
may  ||| S:1180 E:1184 ||| MD
be  ||| S:1184 E:1187 ||| VB
a  ||| S:1187 E:1189 ||| DT
diagnostic  ||| S:1189 E:1200 ||| JJ
clue  ||| S:1200 E:1205 ||| NN
for  ||| S:1205 E:1209 ||| IN
high  ||| S:1209 E:1214 ||| JJ
grade  ||| S:1214 E:1220 ||| NN
glioma ||| S:1220 E:1226 ||| NN
.  ||| S:1226 E:1228 ||| .
On  ||| S:1228 E:1231 ||| IN
( ||| S:1231 E:1232 ||| -LRB-
1 ||| S:1232 E:1233 ||| LS
) ||| S:1233 E:1234 ||| -RRB-
H-MRS ||| S:1234 E:1239 ||| NNP
,  ||| S:1239 E:1241 ||| ,
increased  ||| S:1241 E:1251 ||| VBD
β  ||| S:1251 E:1253 ||| JJ
and  ||| S:1253 E:1257 ||| CC
γ-Glx  ||| S:1257 E:1263 ||| NNS
are  ||| S:1263 E:1267 ||| VBP
most  ||| S:1267 E:1272 ||| RBS
frequently  ||| S:1272 E:1283 ||| RB
found  ||| S:1283 E:1289 ||| VBN
in  ||| S:1289 E:1292 ||| IN
TDL ||| S:1292 E:1295 ||| NNP
.  ||| S:1295 E:1297 ||| .
Dynamic  ||| S:1297 E:1305 ||| JJ
observation  ||| S:1305 E:1317 ||| NN
of  ||| S:1317 E:1320 ||| IN
imaging  ||| S:1320 E:1328 ||| JJ
changes  ||| S:1328 E:1336 ||| NNS
may  ||| S:1336 E:1340 ||| MD
be  ||| S:1340 E:1343 ||| VB
more  ||| S:1343 E:1348 ||| RBR
important  ||| S:1348 E:1358 ||| JJ
for  ||| S:1358 E:1362 ||| IN
facilitating  ||| S:1362 E:1375 ||| VBG
the  ||| S:1375 E:1379 ||| DT
diagnosis  ||| S:1379 E:1389 ||| NN
of  ||| S:1389 E:1392 ||| IN
TDL ||| S:1392 E:1395 ||| NNP
,  ||| S:1395 E:1397 ||| ,
especially  ||| S:1397 E:1408 ||| RB
in  ||| S:1408 E:1411 ||| IN
conjunctions  ||| S:1411 E:1424 ||| NN
with  ||| S:1424 E:1429 ||| IN
imaging  ||| S:1429 E:1437 ||| JJ
characteristics  ||| S:1437 E:1453 ||| NNS
and  ||| S:1453 E:1457 ||| CC
clinical  ||| S:1457 E:1466 ||| JJ
features ||| S:1466 E:1474 ||| NNS
.  ||| S:1474 E:1476 ||| .
